Primacor (Milrinone Lactate Injection) – Uses, Strengths & USA Availability

Primacor (Milrinone Lactate Injection) is an intravenous medicine containing milrinone, a phosphodiesterase-3 inhibitor with both inotropic and vasodilator activity. It is used in hospital and critical-care settings when short-term support of cardiac function is clinically required. Because milrinone injection is a prescription medicine administered intravenously, its use should be determined and monitored by qualified healthcare professionals.

Product Description

Primacor contains milrinone lactate, which helps improve cardiac contractility while also producing vasodilation. This combination can increase cardiac output and reduce certain cardiac filling pressures. U.S. prescribing information describes milrinone lactate injection as a bipyridine inotropic/vasodilator agent that is distinct from digitalis glycosides and catecholamines.

Milrinone injection is administered through an intravenous route and is generally used under continuous clinical monitoring. The medicine may be supplied as a sterile solution in single-dose vials. U.S. labeling includes a 1 mg/mL concentration, with a 20 mL vial containing 20 mg of milrinone equivalent.

Strengths and Presentation

When searching for Primacor or milrinone lactate injection in the USA, buyers should carefully verify the concentration, vial size, manufacturer, labeling, and regulatory status before procurement.

Common U.S.-listed milrinone lactate injection presentations include:

10 mg/10 mL (1 mg/mL)

20 mg/20 mL (1 mg/mL)

50 mg/50 mL (1 mg/mL)

The exact availability of a particular presentation can vary by manufacturer and supplier.

Uses of Milrinone Lactate Injection

Milrinone is used for short-term intravenous treatment of patients with acute heart failure and related situations where increased cardiac output and reduced cardiac filling pressures are clinically desirable. Its pharmacological action combines positive inotropic effects with vasodilation.

Treatment requires appropriate patient assessment because milrinone can affect blood pressure and cardiac rhythm. Patients receiving the medicine should be monitored according to the treating healthcare professional's instructions. Renal impairment is also important because reduced kidney function can increase milrinone exposure and may require adjustment of the infusion rate.

Ordering Milrinone Injection in the USA

Organizations searching for milrinone lactate injection suppliers in the USA, hospital-use medicines, or pharmaceutical sourcing should verify the product's prescription status, regulatory requirements, documentation, packaging, storage conditions, and authorized distribution pathway.

For international pharmaceutical procurement, buyers should confirm that the selected product and shipment comply with applicable U.S. import and prescription-drug requirements. Product availability, packaging, and supply terms should be confirmed before placing an order.

Frequently Asked Questions

What is Primacor?

Primacor is a brand name associated with milrinone, an intravenous phosphodiesterase-3 inhibitor used for short-term cardiovascular support.

Is milrinone injection available by prescription?

Yes. U.S. milrinone lactate injection labeling identifies it as Rx Only and for intravenous use.

How is milrinone administered?

Milrinone is administered intravenously, generally as a loading dose followed by a controlled continuous infusion under professional medical supervision.

Does kidney function affect milrinone treatment?

Yes. Renal impairment can increase the elimination half-life of milrinone, so healthcare professionals may need to adjust the infusion rate.

Can I buy milrinone injection online?

Milrinone is a prescription injectable medicine and is not intended for self-administration. Patients and healthcare organizations should obtain it through an appropriate licensed or authorized pharmaceutical supply channel.